3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
6
NETWORK
2
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Osteoporosis
1
Esophageal Neoplasms
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Bone Diseases, Metabolic
1
Adenocarcinoma
1
Interventions
Zoledronic Acid
4
Letrozole
2
Kyphoplasty
2
Denosumab
2
Toremifene
1
Testosterone
1
Risedronic Acid
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Osteoporosis
×
Risedronic Acid
×
Clear all
NCT00082277
2011-01-26
SABRE
AstraZeneca
Phase 4
Completed
237 enrolled